Gilead's COVID-19 drug remdesivir would be cost effective at a price between $2,500 and $2,800 per treatment course if the steroid dexamethasone is also used to treat patients hospitalized with coronavirus infections, according to a new estimate published Wednesday by the nonprofit group known as ICER.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,